Latest Event Updates

COPD and Asthma Devices Market is Expected to Reach $34.3 Billion, Global, by 2020

Posted on

According to a new report by Allied Market Research titled, “Global COPD and Asthma Devices Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global COPD and asthma devices market would reach $34.3 billionby 2020, registering a CAGR of 4.5% during 2014 – 2020. Considering the growth and market size, Dry Powder Inhalers (DPIs) will be the most lucrative market segment of the COPD and Asthma devices (inhalers) market by 2020. Metered Dose Inhalers (MDIs) are the largest revenue generating segment currently and would maintain the stand till 2020.

To the view the report, visit the website at http://www.alliedmarketresearch.com/COPD-asthma-devices-market

The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices. Despite notable advantages of the COPD and Asthma devices, some factors such as environmental concerns are likely to impede the growth of COPD and Asthma devices market. It is observed that the inhalers, particularly the MDIs, release environmentally-hazardous gases, namely chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA), which is negatively impacting growth of the MDIs segment. Consumption pattern will shift to better alternatives, namely the DPIs. The Soft Mist Inhalers (SMIs), which are another type of inhalers, deliver metered dosage of medication as a soft mist. Such form of drug delivery is ~65% to 80% more efficacious than its peers and will eventually display higher growth as compared to its peers.

Nebulizers, electric or battery powered machines that dispense medication as a fine mist, are ideal for home healthcare set-up for debilitated patients, geriatrics and children. Nebulizers segment thus holds about 13% of the global COPD and Asthma devices market; however, the nebulizers market is forecast to have diminishing growth through 2020 as nebulizers are rendered ineffectual, as POC or portable COPD and Asthma devices due to its larger set up.

Key findings of the study:

  • Drug powder inhalers (DPIs) segment will grow at a CAGR of 5.3% during the forecast period, fastest among all
  • North American market would be one of the most lucrative markets, in terms of growth
  • European market for COPD and asthma devices would reach $10 billion by 2020, with the CAGR of 4.8%
  • Within the nebulizers segment markets, compressor nebulizers would be most lucrative, growing at 7% CAGR during the forecast period and compressor nebulizers would garner 81.5% market share by 2020

Specific focus to achieve product differentiation and thus gain competitive advantage drives the development of new product variants of COPD and Asthma devices. In accordance to the afore-mentioned trend, the market has witnessed steady stream of product launch. Key product manufacturing companies profiled in the report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc. and Baxter International.

Internet Security Market is Expected to Reach $42.8 Billion Globally by 2020 – Allied Market Research

Posted on

According to a new report by Allied Market Research titled, “Global Internet Security Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global internet security market is expected to reach $42.8 billion by 2020, registering a CAGR of 8.1% during 2014 – 2020. The market, driven by demand for software solutions, would experience a shift towards the adoption of cloud based systems. About 80 % of the top companies, today, identify with cloud based security services which have become a prominent market trend.

To view the report, visit the website at http://www.alliedmarketresearch.com/internet-security-market

The rapid uptake of internet based applications ranging from education to government, retail to IT & telecommunications, BFSI to manufacturing and others are threatened by the explosive growth of virus and spam attacks. Cybercrime Practices like, Unethical-hacking, botnets, distributed denial of services (DDoS), malware, spyware, spams, viruses and other such threats, are estimated to reach a figure of $1 trillion, globally. The high burden of security threats is providing growth platform for internet security market to grow at a consistent rate.

Recently, at an International Security Conference held at Europe, serious concerns were raised against ‘Malvertising’, i.e. Malware attack through advertisement links on web-spaces. As such attacks are continuously evolving; the need for efficient internet security solutions is highlighted. The internet security market would flourish in future mainly due to rising online financial transactions and internet usage.

Software security solutions contribute to about 80% of the overall internet security market revenue, owing to widespread adoption of individual & corporate users. However, industry leaders such as Intel, HP and Symantec are investing to develop cloud based security solutions. As an impact of these efforts, managed services would grow at the highest CAGR of 28% over the forecast period, surpassing the revenue contribution by hardware solutions.

Key findings of the study:

  • Global market for internet security is moving forward with BFSI, retail, government and education to provide major growth thrust during the forecast period (2014 – 2020)
  • Security adoption in education application segment will grow at a CAGR of 13.9% during the forecast period, fastest among all applications
  • Asia-Pacific would prove to be one of the most lucrative markets, both in terms of size and growth. It should reach $12.2 billion by the year 2020, at a CAGR of 10.9%
  • The adoption of internet security in education applications should grow rapidly, especially in the Asia-Pacific region at a CAGR of 19.2%.

The market growth is strengthened due to factors such as favorable regulations & policies along with e-commerce & e-governance initiatives. As this industry is in its near maturity stage, companies are strategically focusing on dynamic and innovative product development. The selective focus is on product enhancement in order to gain a competitive advantage. Prominent companies profiled in the report include Symantec, Intel, HP, Cisco, IBM, Microsoft, Kasperkay, and Dell.

Global Insecticides Market is expected to grow to $16.7 Billion by 2020 – Allied Market Research

Posted on

A new market research report by Allied Market Research titled, “Global Insecticides Market – (Type, Geography) Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020”, indicates that the global insecticides’ market would reach $16.7 billion by 2020, registering a CAGR of 5.0% from 2014 to 2020. The Asia-Pacific regional market held over 44% of the total global insecticides’ market in terms of value in the year 2013. Within the Asia-Pacific region, India is the largest market owing to high agricultural production of crops such as sugarcane, paddy, and cotton and also consequent high consumption of allied insecticides. On the other hand, usage of insecticides is gradually declining in developed regional markets such as North America and Europe due to increased production of insect/pest-resistant ‘Genetically Modified’ (GM) crops. As a result, currently, North America and Europe collectively hold about 40% of the global insecticides’ market in terms of volume.

To View the report, visit the website at http://www.alliedmarketresearch.com/insecticides-market

In terms of value, ‘Organophosphate’ insecticides hold nearly 30% market share in the global insecticides’ market by types. ‘Organophosphate’ insecticides are widely used owing to their multiple applications such as fumigant, systemic or contact insecticide. Many large-sized companies such as DOW, Syngenta, and BASF manufacture ‘Organophosphate’ insecticides via trade names – Lorsban, Dursban, Curacron and others. The high demand and ready availability are the factors driving the consumption of the ‘Organophosphate’ insecticides worldwide. Another product type, namely Synthetic Pyrethroid insecticide is also widely used, as it is a broad-spectrum insecticide, stable under direct exposure to sunlight and requires minimum usage to control insects. These benefits are cumulatively adding to the growth/consumption of Synthetic Pyrethroid insecticides. The global insecticides market, however, faces many restraints; for instance, environmental and health-related regulations. Recently, i.e., in September 2014, a new regulation banned the production of Chlorpyrifos insecticide as it was found to be harmful to children. Regulatory control on synthetic insecticides is paving the way of increased usage of bio insecticides in agriculture. As a result, research and development to innovate new categories of bio insecticides is also gaining prominence. In 2015, Montana Department of Commerce, U.S., will fund a project to develop a new fungal bioinsecticide to control bark beetles in forestry.

Cereals & Grains is the principal crop type category, which leads in insecticide consumption (both in terms of value and volume) through 2020. Geographically, Asia-Pacific is the dominant market with nearly 40% market share, as cereals and grains’ production is significantly high in countries such as China and India. In Latin American countries, usage of insecticide is high in fruits and vegetables’ cultivation, placing the region as second largest contributor, with an approximate 30% market share in terms of volume.

Key findings of the study:

  • Sale of Organophosphate insecticide is expected to dominate the global insecticides market during the forecast period
  • In terms of volume, organophosphate segment is expected to grow at a CAGR of 5.3% during the forecast period, highest among all
  • Asia-Pacific would be one of the leading markets, both in terms of market size and growth rate. Asia-Pacific would reach $7.2 billion by 2020, with a CAGR of 4.5%
  • India holds the largest market share in Asia-Pacific region and would generate more than 50% of the revenue through 2020

Companies operating in this market focus on product launches as part of their growth strategy; for instance, in the U.S., DOW Agroscience and Bayer Cropscience launched new insecticides, namely, Sequoia, Closerand Sivanto. Key companies profiled in the report are BASF, Bayer AG, DOW Agriscience LLC, Syngenta AG, Cheminova A/S, FMC Corporation, Adama Agricultural Solutions Ltd, Nufarm Ltd, E.I Du Pont de Numerous and Company and Monsanto.

Allied Market Research: Smart Elevator Market Will Reach $23.16 Billion, Global, by 2020

Posted on

According to a new report by Allied Market Research titled, “Global Smart Elevator Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global smart elevator market would reach $23.16 billion by 2020, registering a CAGR of 13.8% during 2014 – 2020. The market, driven by modernization of existing elevator systems, would experience a radical shift by 2020. With large number of new deployment anticipated in developing Asian counties, new deployments of the smart elevators would take over the modernization revenue by 2020. China alone accounts for about 53% of the upcoming high-rise projects across the world.

To view the report, visit the website at http://www.alliedmarketresearch.com/smart-elevator-market

Globally, the growing number of high-rise buildings has escalated the demand for quick, comfortable, efficient, and secure vertical transportation system. Moreover, global green infrastructure standards and statutory requirements are instrumental in compelling deployment of smart elevators in new structures as well as current infrastructure. “The modernization of conventional elevator systems in developed countries such as U.S., UK, Canada, and France has been major contributor to smart elevator market revenue so far. However, over the period, upcoming high-rise buildings would adopt fresh deployment of smart elevator systems,” noted AMR analyst Bryan Olson. “As a result, new deployment of smart elevators would surpass the modernization segment revenue and contribute more than 52% of the overall smart elevators market revenue,” adds analyst. Technologically advanced features and integration of smart communication, access control and security technology allows smart elevators to cater custom needs of various end use segments such as residential, commercial, healthcare, industrial and hospitality among others. Smart elevators can custom fit to unique requirements of each of these end-user segments and can provide reliability, hygiene, aesthetics, ride and destination control, space, and comfort as may require by the respective end-user.

According to WHO data there is a tremendous change in number of people residing in cities. In 2014, the urban population accounted for 54% of the total world population as compared to 34% in 1960. The estimates suggest that the shift would exemplify during 2015 – 2020 and cities across the world would see 1.8% growth in population every year. Limitation of geographical expansion of cities would result in vertical growth and more number of high-rise projects shall be commissioned, eventually triggering the demand for time, space and energy saving smart elevators.

Key findings of the study:

  • Global market for smart elevators applications is gaining momentum with residential and industrial usages to provide major growth during the forecast period (2014 – 2020)
  • Industrial applications will grow at a CAGR of 16.6% during the forecast period, fastest among all applications
  • Maintenance of smart elevators would unveil another area for monetization, which will pick up after year 2015, with highest CAGR of 49.4%
  • Asia-Pacific would be the lucrative market, both in terms of size and growth. It would reach $5.1 billion by 2020, with fastest CAGR of 19.8%
  • The elevators in upcoming high-rises would be smart elevators to greater extent, which would pose new deployment market as largest revenue contributor by 2020.

Global vendors of vertical transportation systems are now quickly shifting their focus to smart elevators to remain competitive. ThyssenKrupp, which maintains and manages more than 1.1 million elevators, has now integrated cloud to its elevator systems to gather valuable data about systems and sensors to improve its maintenance service. In 2014, Schindler Elevator Corporation successfully completed the installation and modernization of its PORT elevator technology at the Union Plaza office building, Puerto Rico. Moreover, buildings such as the Hearst Tower and the Bank of America in Manhattan, the Humana headquarters in Louisvilleand the Crescent in Dallas are few of the many projects where Schindler Corporation has installed as its smart elevator destination dispatch technology system. The report profiles major players in the smart elevator market, namely ThyssenKrupp, Fujitec, Schindler Holding AG, Fujitec, Honeywell International, Otis Elevator Corporation., Bosch Security Systems, Hitachi Ltd., Mitsubishi Electric Co. Ltd. and Hyundai Elevator Co. Ltd.

Global Catheters Market is Expected to Reach $42.5 Billion by 2020 – Allied Market Research

Posted on

According to a new report by Allied Market Research titled, “Global Catheters Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global catheters market would reach $42.5 billion by 2020, registering a CAGR of 7.5% during 2014 – 2020. Increased usage of catheters in minimally invasive surgeries and the introduction of technologically advanced catheters with improved efficacy contribute to growth of the global catheters market. Cardiovascular catheters are the largest revenue generating segment in the overall catheters market.

To view the report, visit the website at http://www.alliedmarketresearch.com/catheters-market

Growing prevalence of cardiovascular diseases, diabetes and urinary diseases is expected to boost demand for catheters. According to data, 2012 approximately 74,690 new cases of urinary bladder cancer were diagnosed (incidence rate) and it is estimated that, approximately 0.5 million people suffer from urinary bladder cancer (prevalence rate) annually in the United States. Also, catheters are vital component/medical consumable used during several diagnostic procedures. Overall, similar consumption pattern for catheters witnessed in several other medical conditions – has resulted in increased usage of catheters thereby increasing the market size of the global catheters market.

Promoting the further use/adoption of catheters is innovation and development of variants that overcome drawbacks of the conventional catheters; for instance, development of male external catheters minimize chances/incidences of urinary tract infection resulting from insertion of catheters in the patient’s body.

High cost involved in cardiac and neurological procedures and lack of experienced and skilled professionals limit the growth of the global catheters market. Also, increasing incidences of nosocomial infections; for example, catheter-associated urinary tract infections are among the prime factors restricting growth of urological catheters market.

Going forward, developing regional – India and China catheters markets are expected to offer potential opportunities owing to increasing awareness and adoption of minimally invasive procedures (that necessitate usage of catheters).

Key findings of the study:

  • Cardiovascular catheters segment expected to grow at a CAGR of 7.4% during the forecast period, fastest among all
  • Urological catheters is the fastest growing segment growing at the CAGR of 8.2% market share by 2020
  • Currently, North America garners a majority share in the catheters market, in terms of market size. North America would reach$16 billion by 2020, with highest CAGR of 5.5%
  • Asia Pacific market is expected to grow at 8.8% CAGR during the forecast period from 2014-2020 due to improved healthcare infrastructure in emerging economies such as India and China (promoting increased usage of catheters)

Reimbursement for catheters or catheterization procedure varies per product. Recently, enabling regulation i.e. the department of Veterans Affairs (VA), recommended a change in the reimbursement of urological catheters – increasing coverage up to 200 sterile single use catheters per month. Such change in policies is therefore estimated to result in an increased market share of urological catheters.

Key companies profiled in the report are Boston Dickinson Ltd, Bard Medicals, Boston Scientific, Hollister Inc., Edwards Lifesciences, B. Braun Melsungen, Arrow Internationals Inc., Medtronic Inc., Medrad (Bayer AG), Johnson&Johnson and Abbott Laboratories.  Companies operating in the catheters market focus on several strategies such as product launch, collaboration and acquisition. For example, Bard Medicals’s R&D spend of ~8% of the total revenue is intended for development and commercialization of feature-enhanced catheters; overall driving growth of the global catheters market.

Global Market for Diagnostic Testing of Sexually Transmitted Diseases (STDs) is Expected to Reach $167.4 Billion by 2020 – Allied Market Research

Posted on

A new report by Allied Market Research titled, “Global Market for Diagnostic Testing of Sexually Transmitted Diseases (STDs) (Disease Types, Testing Volume, Testing Devices and Geography) – Industry Analysis and Forecast, 2013 – 2020”, considers commercial aspects of the diagnostic testing of sexually transmitted diseases. Based on key trends tracked, it is anticipated that the diagnostic testing market for sexually transmitted diseases is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. The growth in the market is chiefly attributed to the high growth in HIV and HPV testing, especially in Asia Pacificand African regions along with complimenting growth rate of the European market.

To view the report, visit the website at http://www.alliedmarketresearch.com/diagnostic-testing-stds-market

Sexually transmitted diseases or venereal diseases (VDs) are one of the most critical health challenges facing the world today. Rising rate of incidence of fatal STDs, corresponding high-economic burden and consequent implementation of Provider-Initiated Counselling and Testing (PICT) and Client-Initiated Counselling and Testing (CICT) are factors that drive the growth of the diagnostic testing market for STDs. Clinical manifestations of STD, for example, Chlamydia range from Urethritis, Epididymitis, Orchitis, Infertility in men to Cervicitis, Endometritis, Salpingitis, PID, infertility and Perihepatitis in women; and untreated STDs that display such manifestations are often fatal. The risk of transmission of Chlamydia infection from an infected male to a female partner is estimated to be about 40% and from an infected female to male is about 30%. Such high rate of transmission, coupled with high rate of undiagnosed and untreated cases (about 85% of women and 40% of men are asymptomatic), renders huge economic burden on healthcare departments across all countries. To ameliorate such cases, healthcare departments across the world, have initiated national screening and also incentivized voluntary screening. Overall, the afore-mentioned factors result in high testing volume for Chlamydia, which contributes to a larger market share in terms of value. HIV, is incurable and prognosis of HIV leads to numerous infections that result in fatality. HIV infected patients also suffer from other co-infections; HIV and Syphilis have a high co-infection rate of about 25%. Akin to national and voluntary screening implemented for Chlamydia, many healthcare departments implemented CICT and PICT screening for HIV too. Such screening programs are expected to increase HIV testing volumes, which is estimated to reach 2.1 billion by 2020.

Laboratory testing of STDs is significant, despite of the presence of many point-of-care (PoC) testing kits available. Some of the STDs are not diagnosed with point of care methods. For instance, HSV (Herpes Simplex Virus), low-risk HPV (Human Papilloma Virus) and Chancroid that manifest as ‘warts’ on the patient’s skin, require physical examination by the laboratory experts. Also, many of the PoC devices are not yet approved by the regulatory health authorities such as USFDA, owing to deviations in the sensitivity and specificity criteria. For these reasons, laboratory testing is considered to be most reliable and globally accepted method for STD testing; therefore, garners a comparatively larger market share than POC testing.

The report also provides market size and forecast for testing devices used for carrying such tests. The market for STD testing devices was valued at $7.7 billion in 2013 with laboratory testing devices accounted for the most of the market and PoC devices shall grow at fastest rate.

Key findings of the study:

  • Global market for diagnostic testing of STDs is gaining traction with growth in HIV and HPV screening and laboratory testing
  • HIV testing market segment would grow at a CAGR of 10.9% during the forecast period
  • Europe would be one of the lucrative markets in terms of growth. The European STDs testing market would reach $26.8 billion by 2020, with highest CAGR of 13.5% (as compared to other regional markets)
  • HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region

As elaborated earlier, many healthcare institutions provide diagnostic testing services for STDs, such as specialized STD clinics, Genito-Urinary Medicine (GUM) clinics along with general hospitals, government laboratories and private diagnostic centres. The afore-mentioned thus constitute key market participants of the global diagnostic testing of STDs market. Along with the testing service providers, many companies provide devices such as laboratory instruments and POC testing kits/devices for VDs. Companies profiled in this report are Roche Holdings AG, BioMerieux, Hologic Inc., Becton Dickinson & Company, Cepheid Inc., Danaher Corporation, Affymetrix, Alere Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., and DiaSorin.

Wearable Electronics Market is Expected to Reach $25.19 Billion Globally by 2020 – Allied Market Research

Posted on

According to a new report by Allied Market Research titled, “Global Markets for Wearable Electronics (Products, Components, Applications and Geography) – Strategic Analysis and Forecast, 2013 – 2020“, global wearable electronics market is forecast to reach $25.19 billion with a corresponding volume of 142.6 million units by 2020. The market revenue is expected to grow at a CAGR of 26%, while volume would witness a CAGR of 23% during forecast period (2014 – 2020). North America currently holds the largest market share; however, Europe will grow the fastest to become the largest market for wearable electronics.

To view the report, visit the website at http://www.alliedmarketresearch.com/body-adapted-wearable-electronics-market

Usage of wearable is still at its nascent stage; nevertheless, the dawn of mobile wireless systems and smart phones have sparked a new era for wearable electronics, globally. Gadgets, which were deemed to be just used in industrial and commercial applications are now finding place in mundane activities, enhancing quality of life through various applications such as healthcare, sports & fitness, and lifestyle to name a few. The industry is being driven by various factors such as convergence of technologies, rising number of customers adopting digital services, and due to the presence of wireless connectivity. However, lack of design features, higher power usage of wearable devices, high initial investment and users’ concerns regarding data privacy are some of the major challenges for the players operating in wearable electronic space.

The global market for wearable electronics was valued at $4.01 billion in 2013. This includes all forms of wearable electronics, devices, and applications. Lifestyle applications accounted for a major share in the consumer application segment and had 20% market share of the overall market. Further, the market for lifestyle and fitness is anticipated to have the highest growth amongst other applications. Defense and Industrial applications were other major applications, which had over 22% market share of the overall market.

Key Findings of the Report:

The global wearable electronics product market is dominated by wrist wears, which contributes to approximately 45% of the overall market

In terms of applications, lifestyle and fitness segments account for 38% of the overall pie

North America accounts for about 40% of the demand for wearable electronics for both consumer and commercial applications

In terms of product components, memory components account for approximately 23% of the overall market for wearable electronics by components

The market is dominated by large players such as Google, Nike, Adidas, etc. There are a number of small players in the market, who offer products for wearable electronics. However, most of the players are based in the US and this market is slowly but steadily finding its way into other locations targeting other geographies.

Typically, smaller firms have limited scope of operations, both in terms of products and geography. In contrast, leading players have integrated operations through their other offerings such as smart phones, and electronics products. These integrated players work with vendors supplying components and aim to build capabilities across the value chain – from components to retailing finished wearable electronics.

However, companies like Jawbone and Fitbit have raised a lot of capital through funding based on their business ideas and are now competing with large players in the wearable electronics space.